Safety and Effectiveness of D-serine in Schizophrenia
NCT00322023
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
D-serine
DRUG:
D-serine
DRUG:
D-serine
DRUG:
D-serine
Sponsor
Nathan Kline Institute for Psychiatric Research
Collaborators
[object Object]